A record number of Australian GPs and patients now have greater access to Medical Cannabis after a landmark deal was sig...
Vaccine manufacturers seeking listing on the National Immunisation Program (NIP) Schedule must ask for advice from ...
UK based Biocomposites, an international medical devices company that engineers, manufactures and markets world leading ...
Australia based Atomo Diagnostics has announced that it has signed a binding agreement with US-based diagnostics special...
Melbourne-based Affinity Biosciences Pty Ltd (Affinity) has lodged a pre-publication submission to the scientific journa...
The Australian government’s landmark Medical Research Future Fund (MRFF) has reached maturity at $20 billion. This...
The Australian government is backing cutting-edge research into two of the most prominent health conditions that affect ...
Australian government is investing $18.8 million to supercharge the discovery of better treatments for cancer, epilepsy,...
Joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invas...
The Therapeutic Goods Administration (TGA), Division of the Australian Department of Health, has granted pr...
The next critical phase for Australia's University of Queensland’s COVID-19 vaccine is underway – with the r...
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Av...
BellaSeno GmbH, an ISO 13485-certified clinical-stage medtech company developing absorbable scaffolds using additiv...
Monash Institute of Pharmaceutical Sciences (MIPS) in Australia is leading a collaboration of academic and industry part...
The research team, led by Bioresource Processing Institute of Australia (BioPRIA) and Monash University’...
In early June 2020, Australia’s Department of Health offered $13.6 million to support 10 clinical trials rese...
Dr. Harsh Vardhan, Union Minister for Health and Family Welfare, Government of India had a digital interaction with his ...
Australia based CLINUVEL Pharmaceuticals, has announced PRÉNUMBRA®, the Company’s second afamelanotide ...
